Less than 10 people die in Delaware from chronic lower respiratory disease in week ending September 18

 -
-
0Comments

There were less than 10 deaths with chronic lower respiratory disease listed as the underlying cause reported in Delaware during the week ending September 18, a decrease from the previous week, according to The Centers for Disease Control and Prevention.

In the week ending September 18, there were 205 deaths in the state. 17.1 percent of deaths were caused by heart disease, 19.5 percent were from cancer and 36.1 percent were from COVID-19. Additionally, 5.9 percent of deaths were from Alzheimer’s disease and dementia.

Studies show doctors and medical examiners may underreport Alzheimer’s disease and dementia-related conditions as the underlying cause of death on death certificates, according to the National Institute on Aging.

Once infected, older adults with dementia are likely to develop a more severe and dangerous illness. The diseases which make an older adult more vulnerable to COVID-19 are age-associated chronic conditions, according to the Bright Focus Foundation.

Delaware top 10 causes of death in week ending September 18

Cause of Death Number of Deaths 2021-09-18 Number of Deaths 2021-09-11
Malignant neoplasms (cancerous tumor) 40 47
COVID-19 (multiple cause) 38 27
COVID-19 (underlying cause) 36 23
Heart disease 35 41
Cerebrovascular diseases 14 12
Influenza and pneumonia < 10 0
Nephritis, nephrotic syndrome and nephrosis < 10 < 10
Diabetes mellitus < 10 < 10
Alzheimer’s disease < 10 < 10
Chronic lower respiratory diseases < 10 15

Delaware Dementia deaths in week ending September 18
Cause of Death Number of Deaths 2021-09-18 Number of Deaths 2021-09-11
Alzheimer disease and dementia 12 14


Related

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Sussex County man pleads guilty to transporting minor for sexual activity

A Sussex County man has pleaded guilty to transporting a minor across state lines for criminal sexual activity after meeting her online through Snapchat. He faces up to life imprisonment with sentencing set for August.

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Former Delaware physician agrees to pay $180,000 in genetic testing fraud case

Dr. Shayasta S. Mufti has agreed to pay $180,000 after being accused of ordering unnecessary genetic tests for over 100 Medicare patients without proper examinations or consultations between April and November 2019 in Delaware. Authorities say such actions waste taxpayer money and threaten healthcare program integrity.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA reports lowest Q1 inspection count for biologics companies in Delaware

During the first quarter of 2026, the U.S. Food and Drug Administration (FDA) carried out an inspection at a Biologics company in Delaware.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.